Crescent Biopharma (CBIO) Q3 2025 Earnings

31JulConfirmed
Q2 2023
Q3 2023
Q2 2025
Q3 2025
-5
-3.35
-1.69
-0.04

Details

Expected EPS
-1.66715
Actual EPS
-4.93
Surprise EPS
-3.26
Surprise Percent
+195.71%

Description

Crescent Biopharma (CBIO) has reported earnings of -4.93 per share for Q3 2025.

0 Comments

Share your thoughts